GROUP HYDROGEN-EXCHANGE;
CONFORMATIONAL-CHANGES;
IONOTROPIC GLUTAMATE-RECEPTOR-2;
SYNAPTIC-TRANSMISSION;
CRYSTAL-STRUCTURES;
ESCHERICHIA-COLI;
NMR-SPECTROSCOPY;
PARTIAL AGONISTS;
STRUCTURAL BASIS;
ION CHANNELS;
D O I:
10.1074/jbc.M109.086371
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) subtype of ionotropic glutamate receptors mediates much of the fast excitatory neurotransmission in the central nervous system. The ability of these receptors to shape such responses appears to be due in part to dynamic processes induced by agonists in the ligand-binding domain. Previous studies employing fluorescence spectroscopy and whole cell recording suggest that agonist binding is followed by sequential transitions to one or more distinct conformational states. Here, we used hydrogen-deuterium exchange to determine the mechanisms of binding of glutamate and kainate (full and partial agonists, respectively) to a soluble ligand-binding domain of GluR2. Our results provide a structural basis for sequential state models of agonist binding and the free energy changes of the associated state-to-state transitions. For glutamate, a multi-equilibrium binding reaction was discerned involving distinct ligand docking, domain isomerization, and lobe-locking steps. In contrast, kainate binding involves a simpler dock-isomerization process in which the isomerization equilibrium is shifted dramatically toward open domain conformations. In light of increasing evidence that the stability, in addition to the extent, of domain closure is a critical component of the channel activation mechanism, the differences in domain opening and closing equilibria detected for glutamate and kainate should be useful structural measures for interpreting the markedly different current responses evoked by these agonists.
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
Takahashi, M
Kohara, A
论文数: 0引用数: 0
h-index: 0
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
Kohara, A
Shishikura, J
论文数: 0引用数: 0
h-index: 0
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
Shishikura, J
Kawasaki-Yatsugi, S
论文数: 0引用数: 0
h-index: 0
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
Kawasaki-Yatsugi, S
Ni, JW
论文数: 0引用数: 0
h-index: 0
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
Ni, JW
Yatsugi, S
论文数: 0引用数: 0
h-index: 0
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
Yatsugi, S
Sakamoto, S
论文数: 0引用数: 0
h-index: 0
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
Sakamoto, S
Okada, M
论文数: 0引用数: 0
h-index: 0
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
Okada, M
Shimizu-Sasamata, M
论文数: 0引用数: 0
h-index: 0
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
Shimizu-Sasamata, M
Yamaguchi, T
论文数: 0引用数: 0
h-index: 0
机构:
Yamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, JapanYamanouchi Pharmaceut Co Ltd, Inst Drug Dis Res, Neurosci Res Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan
机构:
Astellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, JapanAstellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, Japan
Hashimoto, Tadashi
Miyashita, Aiji
论文数: 0引用数: 0
h-index: 0
机构:
Astellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, JapanAstellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, Japan
Miyashita, Aiji
Nakamura, Eiji
论文数: 0引用数: 0
h-index: 0
机构:
Astellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, JapanAstellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, Japan
Nakamura, Eiji
Sonoda, Takuya
论文数: 0引用数: 0
h-index: 0
机构:
Astellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, JapanAstellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, Japan
Sonoda, Takuya
Noguchi, Kiyoshi
论文数: 0引用数: 0
h-index: 0
机构:
Astellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, JapanAstellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, Japan
Noguchi, Kiyoshi
Oikawa, Keishi
论文数: 0引用数: 0
h-index: 0
机构:
Astellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, JapanAstellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, Japan
Oikawa, Keishi
Minematsu, Tsuyoshi
论文数: 0引用数: 0
h-index: 0
机构:
Astellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, JapanAstellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, Japan
Minematsu, Tsuyoshi
Usui, Takashi
论文数: 0引用数: 0
h-index: 0
机构:
Astellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, JapanAstellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, Japan
Usui, Takashi
Kamimura, Hidetaka
论文数: 0引用数: 0
h-index: 0
机构:
Astellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, JapanAstellas Pharamaceut Co Ltd, Drug Metab Res Labs, Drug Discovery Res, Tokyo, Tokyo, Japan
机构:
Eli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USA
Zmijewski, Milton
Gillespie, Todd A.
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USA
Gillespie, Todd A.
Jackson, David A.
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USA
Jackson, David A.
Schmidt, Douglas F.
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USA
Schmidt, Douglas F.
Yi, Ping
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USA
Yi, Ping
Kulanthaivel, Palaniappan
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Drug Disposit, Lilly Res Labs, Indianapolis, IN 46285 USA